CBI's 5th Annual Forum on Oncology Commercialization Strategies
Conference - Philadelphia, Pennsylvania, U.S.A.
The oncology market represents a huge piece of the pharmaceutical industry and continues to grow at rapid pace. Worldwide sales of cancer drugs are forecasted to increase at a compound annual growth rate reaching $75-80 billion in 2012. This conference brings together industry thought leaders sharing best practices to maximize market access and meet commercial goals.
Case study on the recent approval of Zelboraf
The impact of new health systems on oncology commercialization (ACOs, Patient Centered Medical Homes, etc.)
Incorporating market input to ensure proper target endpoints
The role of pharma in moving toward better quality in cancer care
Global oncology drug access and reimbursement in a volatile market
Tuesday, January 24, 2012 to Wednesday, January 25, 2012
Philadelphia, Pennsylvania, U.S.A.
Contact: (anthony.gulino@cbinet.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
